Retrospective clinical study of the efficacy of lower-dose methotrexate and infliximab therapy in patients with rheumatoid arthritis

scientific article published on 04 March 2010

Retrospective clinical study of the efficacy of lower-dose methotrexate and infliximab therapy in patients with rheumatoid arthritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10067-010-1406-6
P698PubMed publication ID20204668

P2093author name stringAkihiro Sudo
Kusuki Nishioka
Atsumasa Uchida
Masahiro Hasegawa
Hiroshi Oka
Hiroki Wakabayashi
P2860cites workThe american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisQ27860872
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study GroupQ29616063
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study GroupQ33885648
Applying low disease activity criteria using the DAS28 to assess stability in patients with rheumatoid arthritisQ35552614
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanerceptQ35555131
Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold valuesQ35760044
Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?Q35954640
Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patQ35954667
An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody statusQ36772881
Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show a reduced or insufficient response to infliximabQ37209761
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexateQ47784405
The NICE reappraisal of biologics in 2005: what rheumatologists need to knowQ57995952
Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM)Q58204927
The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trialQ74455184
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritisQ77341367
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritisQ82690906
Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?Q83172291
P433issue6
P921main subjectrheumatoid arthritisQ187255
methotrexateQ422232
P304page(s)671-675
P577publication date2010-03-04
P1433published inClinical RheumatologyQ15754927
P1476titleRetrospective clinical study of the efficacy of lower-dose methotrexate and infliximab therapy in patients with rheumatoid arthritis
P478volume29

Reverse relations

cites work (P2860)
Q37345837Certolizumab Pegol Efficacy Across Methotrexate Regimens: A Pre-Specified Analysis of Two Phase III Trials
Q85522624Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
Q51417238Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis.

Search more.